Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 241601000001117 | Eptacog beta (activated) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 241621000001112 | Eptacog beta (activated) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eptacog beta (activated) | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Eptacog beta (activated) | Is a | Product containing coagulation protein (product) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eptacog beta (activated) 2mg (90,000unit) powder and solvent for solution for injection vials | Is a | True | Eptacog beta (activated) | Inferred relationship | Existential restriction modifier | |
| Eptacog beta (activated) 1mg (45,000unit) powder and solvent for solution for injection vials | Is a | True | Eptacog beta (activated) | Inferred relationship | Existential restriction modifier | |
| Eptacog beta (activated) 5mg (225,000unit) powder and solvent for solution for injection vials | Is a | True | Eptacog beta (activated) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR